Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 189,461 |
|
|||||
| News | - | ||||||
| Day High | 0.51 | Low High |
|||||
| Day Low | 0.44 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Cadrenal Therapeutics Inc | CVKD | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.0072 | 1.63% | 0.45 | 23:00:05 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.46 | 0.44 | 0.51 | 0.4801 | 0.4428 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 387 | 189,461 | US$ 0.4805525 | US$ 91,046 | - | 0.36 - 3.14 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:48:02 | 65 | US$ 0.45 | USD |
Cadrenal Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 7.68M | 16.01M | - | 0 | -8.36M | -0.52 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Cadrenal Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CVKD Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.4858 | 0.51 | 0.429 | 0.4566577 | 56,736 | -0.0358 | -7.37% |
| 1 Month | 0.4598 | 0.52 | 0.40 | 0.4547808 | 85,758 | -0.0098 | -2.13% |
| 3 Months | 0.6408 | 0.65 | 0.36 | 0.4381707 | 230,322 | -0.1908 | -29.78% |
| 6 Months | 0.50 | 2.17 | 0.36 | 0.8561214 | 289,543 | -0.05 | -10.00% |
| 1 Year | 1.54 | 3.14 | 0.36 | 1.25 | 257,935 | -1.09 | -70.78% |
| 3 Years | 5.71 | 6.75 | 0.36 | 1.61 | 230,082 | -5.26 | -92.12% |
| 5 Years | 5.71 | 6.75 | 0.36 | 1.61 | 230,082 | -5.26 | -92.12% |
Cadrenal Therapeutics Description
| Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib. |
